PMID: 17495126

Winkler M, Stephan D, Bieger S, Kuhner P, Wolff F, Quast U
Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. Epub 2007 May 10., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 17495126:5:133
status: NEW
view ABCC8 p.Ser1237Tyr details
A-ligands are highly selective in closing the pancreatic channel, whereas B-ligands are nonselective and insensitive to the mutation S1237Y. Login to comment
33 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 17495126:33:94
status: NEW
view ABCC8 p.Ser1237Tyr details
In addition, their potency in closing the pancreatic channel was not affected by the mutation S1237Y in SUR1 (Ashfield et al., 1999; Hansen et al., 2002). Login to comment
39 ABCC8 p.Ser1237Tyr
X
ABCC8 p.Ser1237Tyr 17495126:39:180
status: NEW
view ABCC8 p.Ser1237Tyr details
We evaluated the effect of coexpression with Kir6.x on the affinity of SURx for the insulinotropes, the effect of the mutation SUR2(Y1206S), i.e., the reverse of the mutation SUR1(S1237Y), and the selectivity in binding to the recombinant pancreatic, myocardial, and vascular KATP channels. Login to comment